This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Harry Glorikian
General Partner at Scientia Ventures


Harry Glorikian, M.B.A. General Partner, Scientia Ventures Before joining Scientia Ventures, he served as an Entrepreneur-In-Residence to GE Ventures – New Business Creation Group, leading to the founding of Evidation Health and DrawBridge Health. He currently serves on a number of different boards both public and private. He is also a co-founder and an advisory board member to DrawBridge Health. Harry holds an MBA from Boston University and a bachelor's degree from San Francisco State University. Harry has addressed the NIH, Molecular Medicine Tri-Conference, World Theranostics Congress and other audiences, worldwide. He has authored numerous articles, appeared on CBS Evening News and been quoted regularly by Dow Jones, The Boston Globe, Los Angeles Times, London Independent, Medical Device Daily, Science Magazine, Genetic Engineering News and many others. He is the author of two books: Commercializing Novel IVD’s; A Comprehensive Manual for Success and MoneyBall Medicine: Thriving in the New Data-Driven Healthcare Market and the host of the MoneyBall MedicineÔ podcast series.

Agenda Sessions

  • Investment, Commercialization, and Value Recognition: The AI Healthcare Hurdle

    On Demand